Table 3.
CHW availability of anti-malarial drugs and malaria diagnostics, among anti-malarial-stocking outlets, by region
| CHW Total(N = 1263) (95% CI) |
Eastern (N = 545) (95% CI) |
Central (N = 244) (95% CI) |
Western (N = 242) (95% CI) |
Coastal N = (232) (95% CI) |
|
|---|---|---|---|---|---|
| Availability of anti-malarialsa | |||||
| Any ACTb | 83.1 (80.1, 86.1) | 87.8 (83.9, 90.9) | 76.2 (69.8, 81.6) | 83.3 (76.1, 88.6) | 91.7 (86.2, 95.1) |
| Chloroquine | 67.0 (63.5, 70.5) | 67.6 (63.0, 71.8) | 65.4 (58.8, 71.4) | 76.0 (68.4, 82.3) | 67.3 (59.0, 74.6) |
| Primaquine | 62.6 (58.6, 66.5) | 60.3 (55.3, 65.2) | 58.1 (50.4, 65.3) | 72.7 (64.2, 79.8) | 74.7 (67.5, 80.8) |
| Oral AMT | 2.9 (1.6, 4.2) | 2.4 (1.2, 4.7) | 4.0 (2.1, 7.5) | 4.5 (2.6, 7.9) | 0.6 (0.2, 2.2) |
| Non-oral AMT | 8.9 (6.5, 11.3) | 6.5 (4.1, 10.2) | 12.3 (8.3, 17.8) | 7.9 (5.1, 12.0) | 5.0 (2.4, 10.2) |
| N = 1382 | N = 597 | N = 277 | N = 257 | N = 251 | |
|---|---|---|---|---|---|
| Availability of blood testingc | |||||
| Any malaria blood testing | 77.7 (74.4, 81.0) | 79.3 (75.5, 82.7) | 72.5 (65.6, 78.4) | 83.6 (78.1, 87.9) | 86.1 (79.7, 90.7) |
| Malaria microscopy | 0.2 (0.0, 0.5) | 0.1 (0.0, 0.7) | 0.3 (0.0, 2.1) | 1.1 (0.2, 5.9) | 0.0 |
| RDTs | 77.7 (74.4, 81.0) | 79.3 (75.5, 82.7) | 72.5 (65.6, 78.4) | 83.6 (78.1, 87.9) | 86.1 (79.7, 90.7) |
AMT artemisinin monotherapy
aAnti-malarial-stocking outlets have at least one anti-malarial in stock on the day of the survey, verified by presence of at least one anti-malarial recorded in the ant-imalarial audit sheet
bAt the time of the 2015/2016 Myanmar ACTwatch outlet survey, AL, DHA-PP, and ASMQ were the first-line treatments for uncomplicated falciparum malaria. There was no ASMQ audited during the 2015/2016 survey
cBlood testing availability is reported among outlets that either had anti-malarials in stock on the day of the survey or reportedly stocked anti-malarials in the previous 3 months